Home > Back to Publisher > Report Information

Contract Pharmaceutical Manufacturing, Research and Packaging

BCC Research
October 1, 2009
212 Pages - SKU: WA2493311

Abstract Table of Contents Related Reports

REPORT HIGHLIGHTS

Overall sales in the pharmaceutical contract manufacturing and contract research market were worth nearly $143 million in 2007, which increased to an estimated $177 million in 2009. By 2014, sales are projected to increase to nearly $299 million, for a 5-year CAGR of 11.1%.
The largest segment in the market, contract manufacture of OTC and nutraceuticals, was valued at $82 million in 2007. This increased to an estimated $103 million in 2009, and is projected to reach $177 million in 2014, for a 5-year CAGR of 11.4%.
Sales in the contract manufacture of bulk- and dosage-form drugs segment were worth $36 million in 2007, and were to increase to nearly $44 million in 2009. By 2014, they are projected to increase to $73 million, for a 5-year CAGR of 10.8%.

CHAPTER ONE: INTRODUCTION: STUDY OBJECTIVES; REASONS FOR DOING THIS STUDY; INTENDED AUDIENCE; SCOPE OF THE STUDY; METHODOLOGY; INFORMATION SOURCES; ABOUT THE AUTHOR; RELATED BCC RESEARCH REPORTS; BCC ONLINE SERVICES; DISCLAIMER
CHAPTER TWO: SUMMARY
CHAPTER THREE: OVERVIEW: DEFINITIONS; CONTRACT MANUFACTURING; CONTRACT MANUFACTURER; TYPES OF CONTRACT MANUFACTURERS; CORE COMPETENCIES; VENDOR; CONTRACT RESEARCH ORGANIZATION (CRO); HISTORY OF OUTSOURCING
CHAPTER FOUR: CONTRACT MANUFACTURING: NEED FOR CONTRACT MANUFACTURING; FLEXIBILITY; CAPACITY AND CAPITAL; RISK; ADVANTAGES OF CONTRACT MANUFACTURING; SELECTION OF CONTRACT MANUFACTURER; MISCONCEPTIONS REGARDING CONTRACT MANUFACTURERS
CHAPTER FIVE: CONTRACT RESEARCH: INCLUDED IN RESEARCH; DRUG DISCOVERY AND DEVELOPMENT; CLINICAL RESEARCH; ANALYTICAL RESEARCH; NEED FOR CONTRACT RESEARCH; SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATION; SELECTION AND MANAGEMENT OF CRO
CHAPTER SIX: CONTRACT PACKAGING: CONTRACT PACKAGING; THE NEED FOR CONTRACT PACKAGING; CRITERIA FOR THE SELECTION OF A PACKAGING SERVICE; LOCATION; EXPERIENCE; PERSONALITY; FINANCIAL STRENGTH; ADVANTAGES OF CONTRACT PACKAGING
CHAPTER SEVEN: THE NEED FOR PROJECT MANAGEMENT: PROJECT EVALUATION AND SET UP; PLANNING AND EXECUTION; QUALITY MANAGEMENT; MANAGEMENT OF QUALITY COMPONENTS FROM CLIENT’S PERSPECTIVE; MANAGEMENT OF QUALITY COMPONENTS FROM THE CMO PERSPECTIVE
CHAPTER EIGHT: REGULATORY ASPECTS: SHORT SUPPLY ARRANGEMENTS; DIVIDED MANUFACTURING ARRANGEMENTS; SHARED MANUFACTURING ARRANGEMENTS; RESPONSIBILITIES OF EACH PARTICIPATING MANUFACTURER; CONTRACT MANUFACTURING ARRANGEMENTS; RESPONSIBILITIES OF LICENSED MANUFACTURER; RESPONSIBILITIES OF THE CONTRACT MANUFACTURER; WARNING LETTERS; WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS; APPROVALS OF MANUFACTURING FACILITIES
CHAPTER NINE: INDUSTRY STRUCTURE: MARKET SHARES OF INDUSTRY LEADERS; CONTRACT MANUFACTURERS OF BULK DRUGS AND APIS; CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS; CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS; NONSTERILE; STERILE; CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS; CONTRACT RESEARCH COMPANIES; CONTRACT PACKAGING COMPANIES; TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS
CHAPTER TEN: TECHNOLOGY TRANSFER: REASONS FOR TECHNOLOGY TRANSFER; CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER; PRELIMINARY STEPS TOWARD TECHNOLOGY TRANSFER; STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER; TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER; CONFIDENTIAL DISCLOSURE AGREEMENT (CDA); MATERIAL TRANSFER AGREEMENT (MTA); ASSIGNMENT DEED; LICENSE AGREEMENT; CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS; FACTORS FOR A SUCCESSFUL PROJECT
CHAPTER ELEVEN: NEW DEVELOPMENTS: QUINTILES INC.; COVANCE; CHARLES RIVER LABORATORIES; OTHERS
CHAPTER TWELVE: MARKETS: CONTRACT MANUFACTURING; CONTRACT MANUFACTURE OF BULK DRUGS/APIS; Market Overview; Market Revenue; Market Shares; CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS; Solid Dosage Formulations; Market Overview; Market Revenue; Market Shares; Market by Formulation; Market Revenue; Liquid Dosage Formulations; Market Overview; Non-sterile Formulations; Market Revenue; Market Shares; Sterile Formulations; Market Revenue; Market Shares; Market by Formulation; Non-sterile Formulations; Sterile Formulations; CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS; Market Overview; Market Revenue; Market Shares; Market by Formulation; CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS; Market Overview; Market Revenue; Market Shares; Market by Formulation; Market Shares; CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS; Market Overview; Market Revenue; Market Shares; Market by Formulation; CONTRACT RESEARCH; MARKET OVERVIEW; Partnerships; Expansions of Facilities; MARKET REVENUE; MARKET SHARES; MARKET BY DISCIPLINE; MARKET SHARES BY DISCIPLINE; CONTRACT PACKAGING; MARKET OVERVIEW; MARKET REVENUE; MARKET SHARES; MARKET BY PACKAGE TYPE; MARKET REVENUE; MARKET SHARES
CHAPTER THIRTEEN: CONTRACT MANUFACTURING APPLICATIONS: CARDIOVASCULAR DRUG MARKET; MARKET REVENUE; REPRODUCTIVE DRUG MARKET; MARKET REVENUE; ONCOLOGY DRUG MARKET; MARKET REVENUE; ANALGESIC MARKET; MARKET REVENUE; ANTIVIRAL DRUGS MARKET; MARKET REVENUE; ANTIBIOTICS MARKET; MARKET REVENUE; MARKETS FOR OTHER DRUGS; MARKET REVENUE
CHAPTER FOURTEEN: PATENT ANALYSIS: PATENTS BY YEAR; PATENTS BY COMPANY; PATENTS BY COUNTRY; PATENTS BY EMPHASIS
CHAPTER FIFTEEN: CURRENT ENVIRONMENT: OVERALL SITUATION OF THE CONTRACTING MARKET; CONTRACT MANUFACTURING OF API AND DOSAGE FORMS; CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS; CONTRACT RESEARCH; CONTRACT PACKAGING; SUCCESS FACTORS FOR CMOS; PRESENT SCENARIO OF THE CONTRACT MANUFACTURING MARKET; FROM THE PHARMACEUTICAL COMPANIES’ PERSPECTIVE; FROM CONTRACT MANUFACTURING ORGANIZATION’S PERSPECTIVE; FACTORS AFFECTING THE OUTSOURCING MARKET; COST CONTAINMENT; GLOBALIZATION; MERGERS AND ACQUISITIONS; REGULATORY REQUIREMENTS; NEED FOR SPECIALIZED SERVICES; COMPETITION WITHIN THE PHARMACEUTICAL INDUSTRY; INTRODUCTION OF NEW BIOTHERAPEUTICS
CHAPTER SIXTEEN: COMPANY PROFILES: AAI PHARMA, INC.; ABBOTT LABORATORIES; AEROGEN, INC.; ALBANY MOLECULAR RESEARCH, INC.; ALCAN PACKAGING; ALKERMES, INC.; AMERISOURCE BERGEN; A. P. PHARMA, INC.; ARADIGM CORPORATION; BAXTER HEALTHCARE; BEN VENUE LABORATORIES INC.; BIOVAIL CORP.; BOEHRINGER INGELHEIM; BOOTS MANUFACTURING; CAMBREX CORP.; CANGENE; CATALENT PHARMA SOLUTIONS; CEDARBURG HAUSER PHARMACEUTICAL LTD.; CENEXI; CHARLES RIVER LABORATORIES; CHEMBRIDGE CORP.; CONFAB LABORATORIES; COVANCE INC.; DAVOS PHARMA; DECODE GENETICS; DIOSYNTH BIOTECHNOLOGY; DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.; DOW CHEMICAL COMPANY; DPT LABORATORIES INC.; DR REDDY’S LABORATORIES; DSM PHARMACEUTICAL PRODUCTS; ELAN DRUG TECHNOLOGIES; EVOTEC AG; FULCRUM PHARMA PLC; GENZYME PHARMACEUTICALS; GIRINDUS AG; GLAXOSMITHKLINE BIOPHARMACEUTICALS; HOVIONE S.A; JUBILANT ORGANOSYS; KENDLE INTERNATIONAL INC.; KING PHARMACEUTICALS; KP PHARMACEUTICAL TECHNOLOGIES INC; K.V. PHARMACEUTICAL CO.; LIGAND PHARMACEUTICALS; LONZA GROUP; LYNE LABORATORIES; MALLINCKRODT; MDS PHARMA SERVICES; MEDAREX INC.; MIKART INC; NORWICH PHARMACEUTICALS; NOVAVAX, INC.; OMNICARE CLINICAL RESEARCH; PAREXEL INTERNATIONAL CORPORATION; PATHEON INC.; PERRIGO COMPANY; PHARMACEUTICAL PRODUCT DEVELOPMENT INC.; PIRAMAL HEALTHCARE; PRA INTERNATIONAL; QUINTILES; RANBAXY RESEARCH LABS; REGIS TECHNOLOGIES, INC.; SCHWARZ PHARMA AG; SKYEPHARMA; TALECRIS BIOTHERAPEUTICS INC.; WUXI APP TEC; XCELLEREX, LLC; APPENDIX : ABBREVIATIONS; APPENDIX
LIST OF TABLES: SUMMARY TABLE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2014 ($ BILLIONS); TABLE 1 KEY ADVANTAGES OF CONTRACT MANUFACTURING; TABLE 2 RESPONSIBILITIES OF LICENSED MANUFACTURER UNDER FDA ACTS; TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%); TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%); TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%); TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%); TABLE 7 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%); TABLE 8 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%); TABLE 9 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%); TABLE 10 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS; TABLE 11 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE; TABLE 12 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS); TABLE 13 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); TABLE 14 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS); TABLE 15 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); TABLE 16 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ BILLIONS); TABLE 17 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%); TABLE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS); TABLE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%); TABLE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS); TABLE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); TABLE 22 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS); TABLE 23 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%); TABLE 24 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS); TABLE 25 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%); TABLE 26 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS); TABLE 27 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); TABLE 28 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS); TABLE 29 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%); TABLE 30 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS; TABLE 31 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY REGION, THROUGH 2014 ($ BILLIONS); TABLE 32 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); TABLE 33 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY TYPE, THROUGH 2014 ($ BILLIONS); TABLE 34 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2009 (%); TABLE 35 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS); TABLE 36 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); TABLE 37 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, THROUGH 2014 ($ BILLIONS); TABLE 38 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%); TABLE 39 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, THROUGH 2014 ($ BILLIONS); TABLE 40 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%); TABLE 41 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, THROUGH 2014 ($ BILLIONS); TABLE 42 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%); TABLE 43 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, THROUGH 2014 ($ BILLIONS); TABLE 44 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%); TABLE 45 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, THROUGH 2014 ($ BILLIONS); TABLE 46 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%); TABLE 47 WORLDWIDE REVENUE FROM CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS BY REGION, THROUGH 2014 ($ MILLIONS); TABLE 48 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS); TABLE 49 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS); TABLE 50 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS); TABLE 51 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS); TABLE 52 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS); TABLE 53 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS); TABLE 54 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009; TABLE 55 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2009; TABLE 56 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2009; TABLE 57 PATENT SHARES BY COUNTRY, 2005-2009 (%); TABLE 58 PATENTS BY EMPHASIS, 2005-2009
LIST OF FIGURES: SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2007-2014 ($ BILLIONS); FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%); FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%); FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%); FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%); FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%); FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%); FIGURE 7 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%); FIGURE 8 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS); FIGURE 9 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); FIGURE 10 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS); FIGURE 11 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); FIGURE 12 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ BILLIONS); FIGURE 13 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2009 (%); FIGURE 14 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS); FIGURE 15 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); FIGURE 16 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS); FIGURE 17 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); FIGURE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS); FIGURE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%); FIGURE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS); FIGURE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%); FIGURE 22 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS); FIGURE 23 WORLDWIDE SEMI-SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); FIGURE 24 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS); FIGURE 25 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%); FIGURE 26 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS); FIGURE 27 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); FIGURE 28 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2007-2014 ($ BILLIONS); FIGURE 29 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2009 (%); FIGURE 30 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS); FIGURE 31 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%); FIGURE 32 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, 2007-2014 ($ BILLIONS); FIGURE 33 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%); FIGURE 34 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, 2007-2014 ($ BILLIONS); FIGURE 35 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%); FIGURE 36 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, 2007-2014 ($ BILLIONS); FIGURE 37 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%); FIGURE 38 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, 2007-2014 ($ BILLIONS); FIGURE 39 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%); FIGURE 40 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, 2007-2014 ($ BILLIONS); FIGURE 41 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%); FIGURE 42 WORLDWIDE CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS); FIGURE 43 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS); FIGURE 44 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS); FIGURE 45 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS); FIGURE 46 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS); FIGURE 47 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS); FIGURE 48 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS); FIGURE 49 NUMBER OF PATENTS BY YEAR, 2005-2009; FIGURE 50 NUMBER OF PATENTS BY YEAR, 2005-2009 (%); FIGURE 51 PATENT SHARES BY COUNTRY, 2005-2009 (%)

Contract Pharmaceutical Manufacturing, Research and Packaging

Share this report

Other tasks

Research Assistance

Related Markets

Drug Discovery Reports

Free Alert Me service